Please ensure Javascript is enabled for purposes of website accessibility

SEC Reportedly Probing Altria's $12.8 Billion Stake in E-Cigarette Maker JUUL

By Keith Speights – Feb 21, 2020 at 6:15PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The federal agency is concerned that the tobacco giant failed to adequately disclose the risk it was taking with investing in JUUL.

The U.S. Securities and Exchange Commission (SEC) has launched an investigation into tobacco giant Altria's (MO 1.51%) stake in e-cigarette maker JUUL Labs, according to a report by The Wall Street Journal. SEC regulators are reportedly looking into whether or not Altria fully disclosed to its shareholders the risks associated with its investment in JUUL.

In December 2018, Altria invested $12.8 billion for a 35% stake in JUUL in a deal that pegged the e-cigarette company's value at $38 billion. JUUL remained independent but gained access to Altria's retail channels and logistics expertise.

Man exhaling vape smoke and holding an e-cigarette

Image source: Getty Images.

Risky business

When Altria first invested in JUUL, the tobacco company's CEO, Howard Willard, said that the deal would "have long-term benefits" for Altria shareholders. Those benefits haven't materialized so far. 

In October 2019, Altria wrote down its investment in JUUL by $4.5 billion. This action came on the heels of several actions by federal agencies against JUUL. The U.S. Food and Drug Administration (FDA) took steps toward banning all e-cig flavors except for tobacco and accused JUUL of illegally marketing its products as being safer than traditional cigarettes. The U.S. Federal Trade Commission also launched an investigation into JUUL for targeting teens with its marketing practices. 

Altria wrote down another $4.1 billion in the valuation of its JUUL stake last month. The tobacco giant stated that since its earlier impairment, the number of lawsuits filed against JUUL soared by 80%.

What's next

The SEC has issued subpoenas to both Altria and JUUL, according to The Wall Street Journal. Both companies have reportedly responded to these subpoenas. It's unknown at this point how long the SEC's investigation will last.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Altria Group, Inc. Stock Quote
Altria Group, Inc.
$41.40 (1.51%) $0.61

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.